Work

Ara-C, Topotecan, and Gemtuzumab Ozogamicin [ATGO] Is An Effective Induction Regimen for Advanced MDS and Secondary or Relapsed AML: Analysis of a Phase I/II Study

Year: 2008

Type: article

Source: Blood

DOI: 10.1182/blood.v112.11.3644.3644

Authors: Amelia A Langston, Sujatha Murali, Stephanie McMillan, Leonard T. Heffner, Sagar Lonial, Edmund K. Waller, Christopher R. Flowers, Jonathan Kaufman, Morgan L. McLemore, Rajni Sinha, Mary J Lechowicz, H. Jean Khoury, Elliott F. Winton

Institutions: Emory University, Winship Cancer Institute

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2552228689

FWCI:

Cites:

Cited by:

Related to: 10